Matica Biotechnology is a US-based viral vector and gene therapy CDMO that leverages advanced technologies at its purpose-built cGMP facility. The company specializes in viral vector manufacturing from development to commercialization with expertise in process development, assay development, and cGMP manufacturing. Matica Bio operates across five sites worldwide and offers proprietary technologies including MatiMax cell lines, in-line process monitoring, and single-use technologies for AAV, lentivirus, and other viral vector platforms.
Viral vector manufacturing, AAV production, lentiviral vector production, gene therapy CDMO, process development, assay development, MatiMax proprietary cell lines, single-use technologies
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.